LINQ II Insertable Cardiac Monitor vs Viz RV/LV
AI Verdict
Choose LINQ II Insertable Cardiac Monitor if…
Choose the Medtronic LINQ II if you require long-term, continuous monitoring of a patient's heart rhythm for the diagnosis of infrequent or asymptomatic arrhythmias. This tool is ideal for extended diagnostic periods, offering AI-powered accuracy and remote management capabilities for up to 4.5 years.
View LINQ II Insertable Cardiac Monitor →Choose Viz RV/LV if…
Choose Viz RV/LV if your priority is rapid, AI-powered risk stratification for suspected pulmonary embolism directly from CTPA scans. This solution is best suited for acute care settings where automated right-to-left ventricular ratio measurements are crucial for quick clinical decision-making and efficient care team coordination.
View Viz RV/LV →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | LINQ II Insertable Cardiac Monitor | Viz RV/LV |
|---|---|---|
| Deployment | Subcutaneous implant with remote monitoring via mobile app or home communicator. | Cloud-based |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
LINQ II Insertable Cardiac MonitorTool A offers a broader usability experience, encompassing both patient and clinician needs. Its MyCareLink Heartu2122 mobile app allows patients to easily transmit data and mark symptoms, while remote programming enhances clinician convenience for long-term monitoring.
Clinical Value
TieBoth tools provide significant and distinct clinical value. Tool A excels in long-term, continuous arrhythmia diagnosis with AI-powered accuracy, while Tool B offers rapid, AI-driven risk stratification for acute pulmonary embolism, both addressing critical needs in healthcare.
Pricing & Value
TieNeither Tool A nor Tool B publicly discloses their pricing details, making it impossible to conduct a head-to-head comparison on cost or perceived value. Both operate on an enterprise negotiation model without offering free trials.
Enterprise Readiness
LINQ II Insertable Cardiac MonitorMedtronic, the company behind Tool A, is a long-established global medical device leader with a reported customer base of over 1 million patients for its ICMs, demonstrating extensive proven scalability and a deeply embedded enterprise footprint. While Viz.ai is also robust with FDA clearance and HIPAA compliance, Medtronic's sheer scale and history provide a stronger indicator of enterprise readiness.
Innovation
TieBoth tools showcase significant innovation by applying AI to complex clinical problems. Tool A innovates with AI-powered accuracy and remote programming for an implantable device, while Tool B's real-time, automated imaging analysis for acute conditions and integrated care coordination are equally cutting-edge.
Support & Docs
Viz RV/LVViz.ai (Tool B) explicitly offers 24/7/365 urgent phone support and a comprehensive suite of resources including a Help Center, Customer Resources, and Viz Academy for clinical education. While Medtronic (Tool A) provides extensive documentation and patient service specialists during business hours, Viz.ai's round-the-clock urgent support and dedicated training academy suggest a more robust and readily available support infrastructure for its clinical users.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | LINQ II Insertable Cardiac Monitor | Viz RV/LV |
|---|---|---|
| Name | LINQ II Insertable Cardiac Monitor | Viz RV/LV |
| Company | Medtronic | Viz.ai |
| Description | The Medtronic LINQ II is an advanced, AI-powered insertable cardiac monitor providing long-term, continuous heart rhythm monitoring with remote programming and enhanced accuracy for diagnosing arrhythmias. | Viz RV/LV by Viz.ai is an FDA-cleared AI algorithm that automates right and left ventricular diameter measurements from CTPA scans, providing a crucial RV/LV ratio for rapid pulmonary embolism risk stratification and enhanced care coordination within the Viz PE Solution. |
| Key Features | AccuRhythmu2122 AI algorithms for enhanced accuracy, Remote programming capability, Up to 4.5 years of continuous monitoring, MRI compatibility (1.5 and 3.0T), MyCareLink Heartu2122 mobile app for data transmission, MyCareLink Relayu2122 home communicator option, Innovative PVC detection algorithm, Pediatric indication (ages 2+) | Automated Right Ventricle (RV) to Left Ventricle (LV) ratio measurement, Analysis of volumetric CTPA acquisitions, AI algorithm for identification and measurement of heart ventricles, Provides annotated images showing ventricular measurements, Seamless component of the Viz PE Solution for suspected pulmonary embolism detection, AI-powered alerts and notifications to care teams, High-fidelity mobile DICOM image viewer, HIPAA-compliant communication platform for care coordination |
| Specialties | Cardiology | Emergency Medicine, Pulmonology, Radiology |
| Target Size | Solo to large health systems | Not specified |
| Customer Count | More than 1 million patients have received a Medtronic ICM worldwide | Not specified |
Videos
Demos, reviews, and walkthroughs featuring LINQ II Insertable Cardiac Monitor and Viz RV/LV.